168 related articles for article (PubMed ID: 6687429)
1. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
Randall MJ; Wilding RI
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
[TBL] [Abstract][Full Text] [Related]
2. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
Randall MJ; Wilding RI
Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
[TBL] [Abstract][Full Text] [Related]
3. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
4. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
Parry MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion.
Menys VC; Davies JA
Thromb Haemost; 1983 Apr; 49(2):96-101. PubMed ID: 6346575
[TBL] [Abstract][Full Text] [Related]
6. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
Dodd NJ; Gordge MP; Weston MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
Deckmyn H; Van Houtte E; Verstraete M; Vermylen J
Biochem Pharmacol; 1983 Sep; 32(18):2757-62. PubMed ID: 6578796
[TBL] [Abstract][Full Text] [Related]
8. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Maguire ED; Wallis RB
Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
[TBL] [Abstract][Full Text] [Related]
9. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
[TBL] [Abstract][Full Text] [Related]
10. Effect of dazoxiben on platelet-vessel wall interaction.
Davies JA; Menys VC
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):45S-46S. PubMed ID: 6681703
[TBL] [Abstract][Full Text] [Related]
11. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
[TBL] [Abstract][Full Text] [Related]
12. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis.
Bergqvist D; Björck CG; Dougan P; Esquivel CO; Lannerstad O; Nilsson B; Saldeen P; Saldeen T
Thromb Res; 1985 Feb; 37(3):435-48. PubMed ID: 3838828
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dazoxiben on cerebrovascular resistance in rabbits].
Rui YC; Sun DX; Long K
Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):342-5. PubMed ID: 2624120
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
[TBL] [Abstract][Full Text] [Related]
16. The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis.
Jørgensen KA; Kemp E; Barfort P; Starklint H; Larsen S; Petersen PH; Knudsen JB
Thromb Res; 1983 Dec; 32(6):585-91. PubMed ID: 6364449
[TBL] [Abstract][Full Text] [Related]
17. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
18. Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs.
McDaniel MD; Huntsman WT; Miett TO; Cronenwett JL
Arch Surg; 1987 Aug; 122(8):887-92. PubMed ID: 2957981
[TBL] [Abstract][Full Text] [Related]
19. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man.
Jones EW; Cockbill SR; Cowley AJ; Hanley SP; Heptinstall S
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):39S-44S. PubMed ID: 6401999
[TBL] [Abstract][Full Text] [Related]
20. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
